Integragen Valuation
| ALINT Stock | EUR 0.18 0.01 5.88% |
Integragen seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Integragen from evaluating the firm fundamentals such as Return On Equity of -1.38, return on asset of -0.24, and Current Valuation of (114.78 K) as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Integragen's valuation include:
Price Book 3.4173 | Enterprise Value | Enterprise Value Ebitda (11.66) | Price Sales 0.1829 | Enterprise Value Revenue 0.0808 |
Overvalued
Today
Please note that Integragen's price fluctuation is out of control at this time. Calculation of the real value of Integragen is based on 3 months time horizon. Increasing Integragen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Integragen's intrinsic value may or may not be the same as its current market price of 0.18, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.18 | Real 0.14 | Hype 0.18 |
The intrinsic value of Integragen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Integragen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Integragen helps investors to forecast how Integragen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Integragen more accurately as focusing exclusively on Integragen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Integragen's intrinsic value based on its ongoing forecasts of Integragen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Integragen's closest peers.
Integragen Cash |
|
About Integragen Valuation
The stock valuation mechanism determines Integragen's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Integragen based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integragen. We calculate exposure to Integragen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Integragen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 M | 2.2 M | |
| Pretax Profit Margin | (0.04) | (0.04) | |
| Operating Profit Margin | (0.08) | (0.09) | |
| Net Loss | (0.03) | (0.03) | |
| Gross Profit Margin | 0.18 | 0.19 |
Additional Tools for Integragen Stock Analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.